SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401914-23-000048
Filing Date
2023-11-09
Accepted
2023-11-09 16:02:47
Documents
57
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dare-20230930.htm   iXBRL 10-Q 908501
2 EX-10.2 exhibit102_10q20230930.htm EX-10.2 42994
3 EX-10.3 ex_103performancebonusplan.htm EX-10.3 19370
4 EX-31.1 exhibit311_20230930.htm EX-31.1 15378
5 EX-31.2 exhibit312_20230930.htm EX-31.2 15134
6 EX-32.1 exhibit321_20230930.htm EX-32.1 4249
7 EX-32.2 exhibit322_20230930.htm EX-32.2 4237
13 dare-20230930_g1.jpg GRAPHIC 130914
  Complete submission text file 0001401914-23-000048.txt   5113716

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20230930.xsd EX-101.SCH 42813
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20230930_cal.xml EX-101.CAL 41336
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20230930_def.xml EX-101.DEF 191627
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20230930_lab.xml EX-101.LAB 498972
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20230930_pre.xml EX-101.PRE 302409
51 EXTRACTED XBRL INSTANCE DOCUMENT dare-20230930_htm.xml XML 449037
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 231392195
SIC: 2834 Pharmaceutical Preparations